# SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus

> **NCT03819543** · NA · TERMINATED · sponsor: **University of Manitoba** · enrollment: 10 (actual)

## Conditions studied

- Status Epilepticus

## Interventions

- **DEVICE:** Transcranial Direct Current Stimulation

## Key facts

- **NCT ID:** NCT03819543
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-15
- **Primary completion:** 2020-11-30
- **Final completion:** 2021-08-31
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** COVID-19
- **Last updated:** 2023-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03819543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03819543, "SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03819543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*